@
JMTO RO04-01
‹ÇŠis”ñØœ”ñ‰“Šu“]ˆÚäXŠà‚ɑ΂·‚é—ÊGemcitabine•úŽËü“¯Žž•¹—p—Ö@‚RTŠÔ‰»Šw—Ö@æs‚RTŠÔ‰Á‘¬‘½•ªŠ„–@‚Ƃ̖³ìˆ×‰»‘æ‚Q‘Š—Õ°ŽŽŒ±
–{ŽŽŒ±Žx‰‡‹@\
F
“ú–{E‘½‘ŠÔ—Õ°ŽŽŒ±‹@\
Œ¤‹†ƒOƒ‹[ƒv
@
@
Žå”CŒ¤‹†ŽÒ
F
‹ž“s‘åŠwˆãŠw•”•‘®•a‰@
@•úŽËü‰È@•½‰ª ^а
•›Žå”CŒ¤‹†ŽÒ
F
‹ž“s‘åŠwˆãŠw•”•‘®•a‰@
@•úŽËü‰È@‘剮 ‰Ä¶
“Œv‰ðÍÓ”CŽÒ
F
(à)æ’[ˆã—ÃU‹»à’c
@—Õ°Œ¤‹†î•ñƒZƒ“ƒ^[
Œ¤‹†Ž––±‹Ç
F
“ú–{E‘½‘ŠÔ—Õ°ŽŽŒ±‹@\ Ž––±‹Ç
ŽŽŒ±i’»
F
ƒvƒƒgƒRƒ‹ƒhƒ‰ƒtƒg쬒†
“o˜^ŠJŽn“ú
F
(–¢’è)
“o˜^I—¹“ú
F
(–¢’è)
’ÇÕI—¹“ú
F
(–¢’è)
Œ¤‹†ŠT—v
ŽŸ‰ñì¬
—Õ°ŽŽŒ±‹ÆÑ•ñ‘ˆê——‚Ö
@
@
© COPYRIGHT 1999-2005
JMTO all rights reserved.
This site is link free.
@